BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28288490)

  • 1. Development, In Vitro Characterization, Antitumor and Aerosol Performance Evaluation of Respirable Prepared by Self-nanoemulsification Method.
    Naseri N; Zakeri-Milani P; Hamishehkar H; Pilehvar-Soltanahmadi Y; Valizadeh H
    Drug Res (Stuttg); 2017 Jun; 67(6):343-348. PubMed ID: 28288490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
    Bakhtiary Z; Barar J; Aghanejad A; Saei AA; Nemati E; Ezzati Nazhad Dolatabadi J; Omidi Y
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1244-1253. PubMed ID: 28323493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
    Meenach SA; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    AAPS PharmSciTech; 2014 Dec; 15(6):1574-87. PubMed ID: 25139763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy.
    Nemati E; Mokhtarzadeh A; Panahi-Azar V; Mohammadi A; Hamishehkar H; Mesgari-Abbasi M; Ezzati Nazhad Dolatabadi J; de la Guardia M
    AAPS PharmSciTech; 2019 Feb; 20(3):120. PubMed ID: 30796625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy.
    Rosière R; Gelbcke M; Mathieu V; Van Antwerpen P; Amighi K; Wauthoz N
    Int J Oncol; 2015 Sep; 47(3):1131-42. PubMed ID: 26201404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance.
    Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V
    Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy.
    Satari N; Taymouri S; Varshosaz J; Rostami M; Mirian M
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1265-1277. PubMed ID: 32594775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.
    Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY
    Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.
    Zhou X; Tao H; Shi KH
    Drug Des Devel Ther; 2018; 12():1-8. PubMed ID: 29296076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential.
    Pandey P; Dua K; Dureja H
    Int J Biol Macromol; 2019 Oct; 139():1304-1316. PubMed ID: 31404602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
    Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
    Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.